Back

Fulminant myocarditis due to H1N1 Influenza virus successfully managed with veno-arterial extracorporeal membrane oxygenation (VA-ECMO)

28 August 2026 (13:45 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cases of fulminant and immune-mediated myocarditis Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Katerina Talfanidou

Evangelismos General Hospital, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Steroid-refractory fulminant lymphocytic myocarditis successfully treated with tacrolimus guided by serial cardiovascular magnetic resonance
Doctor Y. Agata (Sapporo, JP)
Slides Video
Presentation thumbnail
Anti-IL5 monoclonal antibody treatment to rescue eosinophilic myocarditis in chronic eosinophilic leukemia: killing two birds with one stone.
Doctor C. Menghi (Padova, IT)
Slides Video
Presentation thumbnail
Sequential fulminant myocarditis and guillain-barre syndrome following influenza A infection : a case report
Doctor A. Alshalawi (Riyadh, SA)
Slides Video

Access the full session

Session thumbnail
Cases of fulminant and immune-mediated myocarditis
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Against the clock: a thrilling journey through fulminant myocarditis, cardiogenic shock, and heart transplant recovery
14 March 2025
thumbnail
Congress Presentation
Acute dengue myocarditis presenting with cardiogenic shock and a non-beating heart under VA-ECMO support: a bridge to recovery
11 May 2026
thumbnail
Congress Presentation
Fulminant myocarditis in a young athlete: hazard or genetic predisposition?
10 May 2026
thumbnail
Congress Presentation
Rare course of a cardiogenic shock.
18 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources